Anandamide amidohydrolase (fatty acid amide hydrolase)

被引:47
|
作者
Ueda, N [1 ]
Yamamoto, S [1 ]
机构
[1] Univ Tokushima, Sch Med, Dept Biochem, Tokushima 7708503, Japan
来源
PROSTAGLANDINS & OTHER LIPID MEDIATORS | 2000年 / 61卷 / 1-2期
关键词
cannabinoid; anandamide; 2-arachidonoylglycerol; anandamide amidohydrolase; fatty acid amide hydrolase;
D O I
10.1016/S0090-6980(00)00052-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anandamide (N-arachidonoylethanolamine) loses its cannabimimetic activity when it is hydrolyzed to arachidonic acid and ethanolamine by the catalysis of an enzyme referred to as anandamide amidohydrolase or fatty acid amide hydrolase. Cravatt's group and our group cloned cDNA of the enzyme from rat, human, mouse and pig, and the primary structures revealed that the enzymes belong to an amidase family characterized by the amidase signature sequence. The recombinant enzyme acted not only as an amidase for anandamide and oleamide, but also as an esterase for 2-arachidonoylglycerol. The reversibility of the enzymatic anandamide hydrolysis and synthesis was also confirmed with a purified recombinant enzyme. Several fatty acid derivatives like methyl arachidonyl fluorophosphonate potently inhibited the enzyme. The enzyme was distributed widely in mammalian organs such as liver, small intestine and brain. However, the anandamide hydrolyzing enzyme found in human megakaryoblastic cells was catalytically distinct from the previously known enzyme. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 50 条
  • [1] Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide
    Day, TA
    Rakhshan, F
    Deutsch, DG
    Barker, EL
    MOLECULAR PHARMACOLOGY, 2001, 59 (06) : 1369 - 1375
  • [2] Inhibition of Vascular Growth by Modulation of the Anandamide/Fatty Acid Amide Hydrolase Axis
    Rieck, Sarah
    Kilgus, Sofia
    Meyer, Johanna H.
    Huang, Hao
    Zhao, Lan
    Matthey, Michaela
    Wang, Xin
    Schmitz-Valckenberg, Steffen
    Fleischmann, Bernd K.
    Wenzel, Daniela
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (12) : 2974 - 2989
  • [3] Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase
    Haller, Victoria L.
    Stevens, David L.
    Welch, Sandra P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 600 (1-3) : 50 - 58
  • [4] Involvement of Fatty Acid Amide Hydrolase and Fatty Acid Binding Protein 5 in the Uptake of Anandamide by Cell Lines with Different Levels of Fatty Acid Amide Hydrolase Expression: A Pharmacological Study
    Bjorklund, Emmelie
    Blomqvist, Anders
    Hedlin, Joel
    Persson, Emma
    Fowler, Christopher J.
    PLOS ONE, 2014, 9 (07):
  • [5] Variation of plasma anandamide levels and fatty acid amide hydrolase expression throughout the menstrual
    El-Talatini, Mona R.
    Taylor, Anthony H.
    Spurling, Susan M.
    Konje, Justin C.
    REPRODUCTIVE SCIENCES, 2008, 15 (02) : 167A - 167A
  • [6] Fatty acid amide hydrolase determines anandamide-induced cell death in the liver
    Siegmund, SV
    Seki, E
    Osawa, Y
    Uchinami, H
    Cravatt, BF
    Schwabe, RF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) : 10431 - 10438
  • [7] A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide
    Fowler, Christopher John
    Bjorklund, Emmelie
    Congiu, Cenzo
    Onnis, Valentina
    FASEB JOURNAL, 2009, 23
  • [8] Studies on the interactions of prostamides with fatty acid amide hydrolase, the anandamide transporter, and VRI receptors
    Bisogno, T
    De Petrocellis, L
    Di Marzo, V
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U456 - U456
  • [9] The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase
    Deutsch, DG
    Glaser, ST
    Howell, JM
    Kunz, JS
    Puffenbarger, RA
    Hillard, CJ
    Anbumrad, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) : 6967 - 6973
  • [10] Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle
    Lazzarin, N
    Valensise, H
    Bari, M
    Ubaldi, F
    Battista, N
    Finazzi-Agró, A
    Maccarone, M
    GYNECOLOGICAL ENDOCRINOLOGY, 2004, 18 (04) : 212 - 218